Exploring the Interplay of Uric Acid and Advanced Oxidation Protein Products Following Myocardial Infarction

Recent studies have underscored the potential elevation of Advanced Oxidation Protein Products (AOPP) and uric acid following myocardial infarction, suggesting their involvement in the development and progression of coronary artery disease and potentially influencing patient outcomes. This study foc...

Full description

Bibliographic Details
Main Authors: Joanna Sikora, Tomasz Wybranowski, Aleksandra Karczmarska-Wódzka, Przemysław Sobczak, Stefan Kruszewski, Zbigniew Włodarczyk
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/14/5/1983
_version_ 1797264822396518400
author Joanna Sikora
Tomasz Wybranowski
Aleksandra Karczmarska-Wódzka
Przemysław Sobczak
Stefan Kruszewski
Zbigniew Włodarczyk
author_facet Joanna Sikora
Tomasz Wybranowski
Aleksandra Karczmarska-Wódzka
Przemysław Sobczak
Stefan Kruszewski
Zbigniew Włodarczyk
author_sort Joanna Sikora
collection DOAJ
description Recent studies have underscored the potential elevation of Advanced Oxidation Protein Products (AOPP) and uric acid following myocardial infarction, suggesting their involvement in the development and progression of coronary artery disease and potentially influencing patient outcomes. This study focuses explicitly on examining uric acid and AOPP in the same patients to address the research gap in these biomarkers’ interplay. Recognizing the dual character of uric acid as both an antioxidant and a pro-oxidant, this study delves into its complex biological implications. An analysis was conducted on 40 patients who had experienced myocardial infarction. AOPP levels were quantified using absorbance at 340 nm. Results demonstrated significantly increased AOPP levels in myocardial infarction patients compared to healthy controls, especially in those with high serum uric acid. The serum uric acid and AOPP relationship exhibits a J-shaped curve, indicating a complex, multifactorial interaction. These findings offer new insights into the intricate relationship between serum uric acid and AOPP in myocardial infarction patients, underscoring the significance of these biomarkers in enhancing our understanding of clinical outcomes and informing targeted management strategies for coronary artery disease.
first_indexed 2024-04-25T00:35:00Z
format Article
id doaj.art-0a5ad97e8b854c24a8a59547aedae7fc
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-04-25T00:35:00Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-0a5ad97e8b854c24a8a59547aedae7fc2024-03-12T16:39:41ZengMDPI AGApplied Sciences2076-34172024-02-01145198310.3390/app14051983Exploring the Interplay of Uric Acid and Advanced Oxidation Protein Products Following Myocardial InfarctionJoanna Sikora0Tomasz Wybranowski1Aleksandra Karczmarska-Wódzka2Przemysław Sobczak3Stefan Kruszewski4Zbigniew Włodarczyk5Research and Education Unit for Experimental Biotechnology, Department of Transplantology and General Surgery, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, PolandDepartment of Biophysics, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-094 Bydgoszcz, PolandResearch and Education Unit for Experimental Biotechnology, Department of Transplantology and General Surgery, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, PolandDr Jan Biziel’s University Hospital, Ujejskiego Street 75, 85-168 Bydgoszcz, PolandDepartment of Biophysics, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-094 Bydgoszcz, PolandDepartment of Transplantology and General Surgery, Faculty of Medicine, Collegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, PolandRecent studies have underscored the potential elevation of Advanced Oxidation Protein Products (AOPP) and uric acid following myocardial infarction, suggesting their involvement in the development and progression of coronary artery disease and potentially influencing patient outcomes. This study focuses explicitly on examining uric acid and AOPP in the same patients to address the research gap in these biomarkers’ interplay. Recognizing the dual character of uric acid as both an antioxidant and a pro-oxidant, this study delves into its complex biological implications. An analysis was conducted on 40 patients who had experienced myocardial infarction. AOPP levels were quantified using absorbance at 340 nm. Results demonstrated significantly increased AOPP levels in myocardial infarction patients compared to healthy controls, especially in those with high serum uric acid. The serum uric acid and AOPP relationship exhibits a J-shaped curve, indicating a complex, multifactorial interaction. These findings offer new insights into the intricate relationship between serum uric acid and AOPP in myocardial infarction patients, underscoring the significance of these biomarkers in enhancing our understanding of clinical outcomes and informing targeted management strategies for coronary artery disease.https://www.mdpi.com/2076-3417/14/5/1983uric acidcardiovascular diseasesmyocardial infarctionadvanced oxidation protein productsreactive oxygen species
spellingShingle Joanna Sikora
Tomasz Wybranowski
Aleksandra Karczmarska-Wódzka
Przemysław Sobczak
Stefan Kruszewski
Zbigniew Włodarczyk
Exploring the Interplay of Uric Acid and Advanced Oxidation Protein Products Following Myocardial Infarction
Applied Sciences
uric acid
cardiovascular diseases
myocardial infarction
advanced oxidation protein products
reactive oxygen species
title Exploring the Interplay of Uric Acid and Advanced Oxidation Protein Products Following Myocardial Infarction
title_full Exploring the Interplay of Uric Acid and Advanced Oxidation Protein Products Following Myocardial Infarction
title_fullStr Exploring the Interplay of Uric Acid and Advanced Oxidation Protein Products Following Myocardial Infarction
title_full_unstemmed Exploring the Interplay of Uric Acid and Advanced Oxidation Protein Products Following Myocardial Infarction
title_short Exploring the Interplay of Uric Acid and Advanced Oxidation Protein Products Following Myocardial Infarction
title_sort exploring the interplay of uric acid and advanced oxidation protein products following myocardial infarction
topic uric acid
cardiovascular diseases
myocardial infarction
advanced oxidation protein products
reactive oxygen species
url https://www.mdpi.com/2076-3417/14/5/1983
work_keys_str_mv AT joannasikora exploringtheinterplayofuricacidandadvancedoxidationproteinproductsfollowingmyocardialinfarction
AT tomaszwybranowski exploringtheinterplayofuricacidandadvancedoxidationproteinproductsfollowingmyocardialinfarction
AT aleksandrakarczmarskawodzka exploringtheinterplayofuricacidandadvancedoxidationproteinproductsfollowingmyocardialinfarction
AT przemysławsobczak exploringtheinterplayofuricacidandadvancedoxidationproteinproductsfollowingmyocardialinfarction
AT stefankruszewski exploringtheinterplayofuricacidandadvancedoxidationproteinproductsfollowingmyocardialinfarction
AT zbigniewwłodarczyk exploringtheinterplayofuricacidandadvancedoxidationproteinproductsfollowingmyocardialinfarction